These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of IgG avidity in eyes with active Toxoplasma retinochoroiditis. Lakhmawar P; Kelgaonkar A; Patel A; Khalsa A; Basu S Indian J Ophthalmol; 2024 Jul; 72(Suppl 4):S601-S605. PubMed ID: 38324620 [TBL] [Abstract][Full Text] [Related]
6. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis. Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405 [TBL] [Abstract][Full Text] [Related]
7. Unilateral Acute Macular Toxoplasmic Chorioretinitis Associated with White Dot-Like Choroidal Involvement Demonstrated on Indocyanine Green Angiography. İpek ŞC; Çakar Özdal P; Kavukçu S; Saatci AO Turk J Ophthalmol; 2020 Aug; 50(4):248-251. PubMed ID: 32854470 [TBL] [Abstract][Full Text] [Related]
8. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran. Hosseini SM; Moghaddas E; Sharifi K; Dadgar Moghaddam M; Shamsian SA Int Ophthalmol; 2018 Dec; 38(6):2527-2533. PubMed ID: 29335806 [TBL] [Abstract][Full Text] [Related]
9. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting. Bhikoo R; Damato EM; Guest S; Sims J Korean J Ophthalmol; 2019 Dec; 33(6):514-519. PubMed ID: 31833248 [TBL] [Abstract][Full Text] [Related]
10. Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil. Silveira C; Muccioli C; Holland GN; Jones JL; Yu F; de Paulo A; Belfort R Am J Ophthalmol; 2015 Jun; 159(6):1013-1021.e3. PubMed ID: 25743340 [TBL] [Abstract][Full Text] [Related]
12. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1). Oréfice JL; Costa RA; Scott IU; Calucci D; Oréfice F; Acta Ophthalmol; 2013 Feb; 91(1):e41-7. PubMed ID: 22970804 [TBL] [Abstract][Full Text] [Related]
13. Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis. Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE Am J Ophthalmol; 2020 May; 213():195-202. PubMed ID: 31926883 [TBL] [Abstract][Full Text] [Related]
14. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Wallon M; Kodjikian L; Binquet C; Garweg J; Fleury J; Quantin C; Peyron F Pediatrics; 2004 Jun; 113(6):1567-72. PubMed ID: 15173475 [TBL] [Abstract][Full Text] [Related]
15. Toxoplasmosis in the outer retina. Miokovic AP; Ratkovic M; Gadzo AP Rom J Ophthalmol; 2024; 68(2):198-201. PubMed ID: 39006325 [No Abstract] [Full Text] [Related]
16. Clinical features and prognosis in ocular toxoplasmosis. Atmaca LS; Simsek T; Batioglu F Jpn J Ophthalmol; 2004; 48(4):386-91. PubMed ID: 15295668 [TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Felix JP; Lira RP; Zacchia RS; Toribio JM; Nascimento MA; Arieta CE Am J Ophthalmol; 2014 Apr; 157(4):762-766.e1. PubMed ID: 24388839 [TBL] [Abstract][Full Text] [Related]
18. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090 [TBL] [Abstract][Full Text] [Related]